TY  - GEN
AU  - Takeshita,Akihiro
AU  - Asou,Norio
AU  - Atsuta,Yoshiko
AU  - Sakura,Toru
AU  - Ueda,Yasunori
AU  - Sawa,Masashi
AU  - Dobashi,Nobuaki
AU  - Taniguchi,Yasuhiro
AU  - Suzuki,Rikio
AU  - Nakagawa,Masaru
AU  - Tamaki,Shigehisa
AU  - Hagihara,Maki
AU  - Fujimaki,Katsumichi
AU  - Furumaki,Hiroaki
AU  - Obata,Yukako
AU  - Fujita,Hiroyuki
AU  - Yanada,Masamitsu
AU  - Maeda,Yoshinobu
AU  - Usui,Noriko
AU  - Kobayashi,Yukio
AU  - Kiyoi,Hitoshi
AU  - Ohtake,Shigeki
AU  - Matsumura,Itaru
AU  - Naoe,Tomoki
AU  - Miyazaki,Yasushi
TI  - Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study
SN  - 1476-5551
PY  - 2019///0520
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Benzoates
KW  - therapeutic use
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Leukemia, Promyelocytic, Acute
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Prospective Studies
KW  - Remission Induction
KW  - Salvage Therapy
KW  - Survival Rate
KW  - Tetrahydronaphthalenes
KW  - Young Adult
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/s41375-018-0233-7
ER  -